3 documents found

MiR-221, miR-320a, miR133a, and miR-133b as potential biomarkers in leiomyosarcoma

Background: Leiomyosarcoma is an aggressive tumor with a high rate of distant metastasis and poor prognosis. No standardized biomarkers are available to assess early diagnosis or monitoring during the clinical course. MicroRNAs (miRNAs) function in modulating a multitude of targets and are involved in…
Lausanne: Frontiers Media S.A., 2025-06-20

Exceptional response to neoadjuvant targeted therapy with the selective RET inhibitor selpercatinib in RET -fusion-associated…

With the increasing use of next-generation sequencing, highly effective targeted therapies have been emerging as treatment options for several cancer types. Recurrent gene-fusions have been recognized in sarcomas; however, options for targeted therapy remain scarce. Here, we describe a case of a sarcoma,…
Berlin: Springer, 2023-08

Real-time molecular imaging of near-surface tissue using Raman spectroscopy

The steady progress in medical diagnosis and treatment of diseases largely hinges on the steady development and improvement of modern imaging modalities. Raman spectroscopy has attracted increasing attention for clinical applications as it is label-free, non-invasive, and delivers molecular fingerprinting…
London: Nature Publishing Grou, 2022-04-08